NCT00409357
- Conditions
- Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
- Locations
-
- Sanofi-Aventis Tokyo, Japan
Clinical trial condition
Benign Prostatic Hyperplasia
Explore clinical trials studying Benign Prostatic Hyperplasia. Study availability and eligibility vary by location and protocol.
277 public trials
46 recruiting studies
Benign Prostatic Hyperplasia trial results
NCT00347061
- Conditions
- Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
- Locations
-
- Sanofi-Aventis Tokyo, Japan
NCT00890851
- Conditions
- Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
- Locations
-
- Hôpital TENON - Service d'Urologie Paris, France
NCT00384930
- Conditions
- Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Greenwood, Indiana, United States
NCT00386009
- Conditions
- Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Newport Beach, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tarzana, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Middlebury, Connecticut, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orlando, Florida, United States
Completed
Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction
NCT00827814
- Conditions
- Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
NCT00908427
- Conditions
- Benign Prostatic Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
Completed
Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH
NCT00359905
- Conditions
- Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
- Locations
-
- Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital Sheffield, United Kingdom
Completed
Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate Hyperplasia
NCT00593593
- Conditions
- Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
- Locations
-
Not specified
NCT00199550
- Conditions
- BPH, Benign Prostatic Hyperplasia, Genital Diseases, +5 more
- Locations
-
- Alberta Urology Institute Research Centre Edmonton, Alberta, Canada
- Prostate Centre at Vancouver General Hospital Vancouver, British Columbia, Canada
- Can-Med Clinical Research Inc Victoria, British Columbia, Canada
- Hamilton District Urology Associaton Hamilton, Ontario, Canada